[HTML][HTML] The evolution of Ki-67 and breast carcinoma: past observations, present directions, and future considerations
BS Finkelman, H Zhang, DG Hicks, BM Turner - Cancers, 2023 - mdpi.com
Simple Summary Cellular proliferation is a central determinant of breast cancer recurrence
risk and response to chemotherapy. The discovery of the Ki-67 antibody by Dr. Johannes …
risk and response to chemotherapy. The discovery of the Ki-67 antibody by Dr. Johannes …
Expression, assessment and significance of Ki67 expression in breast cancer: an update
Ki67 expression is one of the most important and cost-effective surrogate markers to assess
for tumour cell proliferation in breast cancer (BC). The Ki67 labelling index has prognostic …
for tumour cell proliferation in breast cancer (BC). The Ki67 labelling index has prognostic …
[HTML][HTML] Evaluating the expression of heat shock protein 27 and topoisomerase II α in a retrospective cohort of patients diagnosed with locally advanced breast cancer …
Y Zhuang, F Zhang, Y Xu, L He, W Huang… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Neoadjuvant anthracycline-based chemotherapy (NAC) is a major regimen for
the treatment of local advanced breast cancer (LABC), while resistance to NAC remains a …
the treatment of local advanced breast cancer (LABC), while resistance to NAC remains a …
[HTML][HTML] The medicinal mushroom Ganoderma lucidum attenuates UV-induced skin carcinogenesis and immunosuppression
The medicinal mushroom Ganoderma lucidum is traditionally used for treating multiple
diseases, including cancer. This study examined skin cancer preventive activity of a …
diseases, including cancer. This study examined skin cancer preventive activity of a …
[HTML][HTML] Ki67 index changes and tumor-infiltrating lymphocyte levels impact the prognosis of triple-negative breast cancer patients with residual disease after …
Y Wang, B Zong, Y Yu, Y Wang, Z Tang, R Chen… - Frontiers in …, 2021 - frontiersin.org
Purpose The aim of this study was to assess the prognostic influence of Ki67 index changes
in patients with primary triple-negative breast cancer (TNBC) treated with neoadjuvant …
in patients with primary triple-negative breast cancer (TNBC) treated with neoadjuvant …
[HTML][HTML] Pre-and post-neoadjuvant clinicopathological parameters can help in the prognosis and the prediction of response in HER2+ and triple negative breast …
L Pons, L Hernández, A Urbizu, P Osorio… - Cancers, 2023 - mdpi.com
Simple Summary HER2+ and triple negative breast cancers are widely known for their
aggressiveness, frequent resistance to treatment and poor prognosis. Neoadjuvant …
aggressiveness, frequent resistance to treatment and poor prognosis. Neoadjuvant …
[HTML][HTML] An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
Objective: In this study, we aimed to develop an amino-terminal fragment (ATF) peptide-
targeted liposome carrying β-elemene (ATF 24-PEG-Lipo-β-E) for targeted delivery into …
targeted liposome carrying β-elemene (ATF 24-PEG-Lipo-β-E) for targeted delivery into …
Clinical characteristics and prognosis of acral lentiginous melanoma: a single‐center series of 211 cases in China
L Wang, J Wu, Z Dai, S Ji, R Jiang - 2021 - Wiley Online Library
Background Acral lentiginous melanoma (ALM) is common in China with poor prognosis.
However, there are only a few studies of ALM in the Asian population. We aimed to …
However, there are only a few studies of ALM in the Asian population. We aimed to …
[PDF][PDF] Changes in Ki67 expression and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer (LABC)
DGAP Devi, H Purwanto, W Sandhika - Bali Medical Journal, 2021 - academia.edu
ABSTRACT Background: Locally Advanced Breast Cancer (LABC) is still the most common
stage found in breast cancer patients in Indonesia. Neoadjuvant Chemotherapy (NAC) is the …
stage found in breast cancer patients in Indonesia. Neoadjuvant Chemotherapy (NAC) is the …
[PDF][PDF] Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong breast cancer registry
YHY Chan, CCH Kwok, DMS Tse, HM Lee, PY Tam… - Hong Kong Med J, 2023 - hkmj.org
Introduction: Neoadjuvant chemotherapy (NAC) was initially used for locally advanced or
inoperable breast cancers. Its extension to early disease has facilitated breast-conserving …
inoperable breast cancers. Its extension to early disease has facilitated breast-conserving …